Archive of stories pre April 2007 | Drug-coated stents used to prop open blocked arteries may cause potentially fatal blood clots in rare cases, said experts at the World Cardiology Congress (WCC) in Barcelona. Safety concerns were raised when a Swiss-Dutch study presented at the WCC said recipients of drug-coated stents were at increased risk of potentially-fatal thrombosis (blood clots). The study tracked 8,146 patients. Two other Swiss studies also reported that drug-coated stents had higher risk of thrombosis compared to bare-metal stents that are not medicated.
Drug-coated stents are preferred over bare-metal stents by many interventionists because they bring down risk of artery re-blockage (restenosis) from about 25 per cent to less than 10 per cent. Drug-coated stents have been implanted in almost 60 lakh people worldwide since they were introduced in 2000, with about 1.5 lakh people using them in India since June 2002.
According to the Interventional Council of India, 60 per cent of the 65,000 stents implanted in India last year were drug-coated.
But now cardologists say the drug-coated therapy may be too aggressive. Bare metal stents allow a thin layer of cells to grow over them to make a biological lining. The medicines in the drug-coated ones, however, prevent tissue growth to could block the arteries from growing. While too much tissue growth is bad, a thin layer of cells is essential to cover the exposed metal, which if not covered can cause clotting and block arteries.
“When the polymer used to deliver the medicines in drug-coated stents is too aggressive, it remains on the stent for over six months to a year and continues to prevent cell-coating from forming. This increases risk of long-term clotting. New generation drug-coated stents are using less-aggressive bio-stable polymers to overcome this problem,” says Swaminathan Jayaraman, CEO of the Bangalore-based Vascular Concepts, the manufacturers of Pro-Nova.
While there has been a shift away from using drug-coated stents in the US, cardiologists in India say these devices cannot be ignored in India because they bring down risk of restenosis. “Since most Indians have diffused heart disease with multiple and longer blockages, and complications such as diabetes, they cannot undergo repeat procedures, so I’d still recommend drug-coated stents for the main arteries,” says Dr Purshotam Lal, director of interventional cardiology at Metro Heart Institute and a member of the health ministry’s expert committee set up to regulate cardiovascular devices (including stents) in India.
Source For Full Article :
Click Here
Credit To Author.
Disclaimer
This website contains copyrighted news material - the use of which has
not always been specifically authorized by the copyright owner. We believe
that our use of such material for nonprofit educational purposes (and other
related purposes) constitutes a 'fair use' of the copyrighted material as
provided for in the US Copyright Law at Title 17 U.S.C. Section 107. If you
wish to use this copyrighted material for purposes of your own that go
beyond 'fair use', you must obtain permission from the copyright owner. If
for any reason you believe that our use of your material on this site does
not fall within the fair use guidelines, please immediately notify The Black
Vault so that we can promptly address the matter.
Sincerely,
John Greenewald, Jr.
The Black Vault Headquarters
http://www.blackvault.com
|
Online Stats: 
